These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28161379)
1. Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder. Fukui S; Aoki K; Morizawa Y; Miyake M; Fujimoto K Urology; 2017 May; 103():214-217. PubMed ID: 28161379 [TBL] [Abstract][Full Text] [Related]
2. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker. Oktar T; Kocak T; Oner-Iyidogan Y; Erdem S; Seyithanoglu M; Ziylan O; Kocak H J Pediatr Urol; 2013 Oct; 9(5):617-21. PubMed ID: 22789557 [TBL] [Abstract][Full Text] [Related]
3. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome. Kim SR; Moon YJ; Kim SK; Bai SW Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766 [TBL] [Abstract][Full Text] [Related]
4. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Liu HT; Kuo HC Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272 [TBL] [Abstract][Full Text] [Related]
5. Urinary nerve growth factor and a variable solifenacin dosage in patients with an overactive bladder. Ciftci S; Ozkurkcugil C; Yilmaz H; Ustuner M; Yavuz U; Yuksekkaya M; Cekmen MB Int Urogynecol J; 2016 Feb; 27(2):275-80. PubMed ID: 26310546 [TBL] [Abstract][Full Text] [Related]
6. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Liu HT; Kuo HC Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891 [TBL] [Abstract][Full Text] [Related]
7. Could urinary nerve growth factor and bladder wall thickness predict the treatment outcome of children with overactive bladder? Huseynov A; Telli O; Haciyev P; Okutucu TM; Akinci A; Ozkidik M; Erguder I; Fitoz S; Burgu B; Soygur T Int Braz J Urol; 2022; 48(3):553-560. PubMed ID: 35373950 [TBL] [Abstract][Full Text] [Related]
8. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Liu HT; Lin H; Kuo HC Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717 [TBL] [Abstract][Full Text] [Related]
9. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding. Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107 [TBL] [Abstract][Full Text] [Related]
10. Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics. Cho KJ; Kim HS; Koh JS; Kim JC Int Urogynecol J; 2013 Feb; 24(2):325-30. PubMed ID: 22717785 [TBL] [Abstract][Full Text] [Related]
11. Urinary nerve growth factor in women with overactive bladder syndrome. Liu HT; Chen CY; Kuo HC BJU Int; 2011 Mar; 107(5):799-803. PubMed ID: 20804479 [TBL] [Abstract][Full Text] [Related]
12. Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder. Wang LW; Han XM; Chen CH; Ma Y; Hai B Int Urol Nephrol; 2014 Feb; 46(2):341-7. PubMed ID: 23982767 [TBL] [Abstract][Full Text] [Related]
13. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Sheng W; Zhang H; Ruth KH Neurourol Urodyn; 2017 Sep; 36(7):1703-1710. PubMed ID: 28102552 [TBL] [Abstract][Full Text] [Related]
14. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. Liu HT; Chancellor MB; Kuo HC BJU Int; 2009 Jun; 103(12):1668-72. PubMed ID: 19220267 [TBL] [Abstract][Full Text] [Related]
15. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis? Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999 [TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? Seth JH; Sahai A; Khan MS; van der Aa F; de Ridder D; Panicker JN; Dasgupta P; Fowler CJ BJU Int; 2013 Mar; 111(3):372-80. PubMed ID: 23444927 [TBL] [Abstract][Full Text] [Related]
17. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Yokoyama T; Kumon H; Nagai A Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444 [TBL] [Abstract][Full Text] [Related]
18. Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome. Silva-Ramos M; Silva I; Oliveira O; Ferreira S; Reis MJ; Oliveira JC; Correia-de-Sá P PLoS One; 2013; 8(5):e64696. PubMed ID: 23741373 [TBL] [Abstract][Full Text] [Related]
19. Nerve Growth Factor and Brain-Derived Neurotrophic Factor as Potential Biomarkers of Mirabegron Efficacy in Patients with Overactive Bladder Syndrome. Beta A; Giannouli A; Rizos D; Mantzou A; Deligeoroglou E; Bakas P Int Urogynecol J; 2024 Jun; 35(6):1317-1322. PubMed ID: 38761233 [TBL] [Abstract][Full Text] [Related]
20. Urinary brain-derived neurotrophic factor and nerve growth factor as noninvasive biomarkers of overactive bladder in children. Colic M; Rogic D; Lenicek Krleza J; Kozmar A; Stemberger Maric L; Abdovic S Biochem Med (Zagreb); 2022 Oct; 32(3):030706. PubMed ID: 36277428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]